Barbara Zylberg
Associate
Barbara focuses on secured and unsecured bank finance matters, including investment grade credit facilities, letters of credit, multi-currency credits and leveraged financings.
Barbara represents financial institutions, hedge funds, sovereign wealth funds, and public and private companies including Mubadala, CVS Health, Quest Diagnostics, Valvoline, Tudor Investment Corporation, Citibank, N.A. and Goldman Sachs.
Expertise
Experience
Representative matters
CVS Health Corporation, as borrower, on (i) a $49 billion senior unsecured bridge facility and (ii) a $5 billion a senior unsecured term loan facility, in each case, agented by Barclays, to finance, in part, the cost of CVS’s acquisition of Aetna Inc.
CVS Health Corporation, as borrower, on its senior unsecured revolving credit facilities agented by Bank of America, N.A. in the aggregate principal amount of $7.5 billion.
Quest Diagnostics Inc., as borrower, on its $750 million senior unsecured revolving credit facility agented by JPMorgan Chase Bank, N.A.
CSW Industrials, Inc., as borrower, on its $400 million senior secured revolving credit facility agented by JPMorgan Chase Bank, N.A.
Published Work
- Zylberg, Barbara, Co-author, (2009) “US Project Finance Chapter,” Getting the Deal Through—Project Finance
Qualifications
Admissions
Attorney-at-Law, Israel, 2003
Attorney-at-Law, New York State (Second Dept), 2006
Brussels Bar, Belgium, 2024
Academic
L.L. B., Bachelor of Laws, Bar Ilan University, 2003
L.L. M., Master of Laws, New York University, 2005
Languages
English
French
Hebrew
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.